International Journal of Nanomedicine

ISSN: 1178-2013

The following Article Collections/ Thematic Series are currently open for submissions:

Design, Development, and Translational Science of Inhaled Nanomedicines for Pulmonary, Nasal, and Nose-to-Brain Delivery

Plant-based Nanoparticles for Advanced Medical Applications: Current Trends and Future Prospects

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Plant-based Nanoparticles for Advanced Medical Applications: Current Trends and Future Prospects", organized by Guest Advisor Dr. Alfredo Ambrosone (University of Salerno, Italy).

Phyto-nanomedicine is an emerging field that aims to leverage the unique properties of plant-based nanoparticles for medical applications. This interdisciplinary field brings together expertise in materials science, plant science, chemistry, biology, and medicine to develop innovative approaches to drug delivery and disease treatment.
The use of plant-based materials in nanomedicine offers several advantages over traditional drug delivery systems. These nanoparticles have biocompatibility, biodegradability, and minimal side effects, making them an attractive alternative to synthetic materials. The use of phyto-nanoparticles can also enhance the bioavailability of drugs, leading to improved therapeutic outcomes. The potential applications of phyto-nanoparticles in disease treatment are vast, with promising results in the treatment of cancer, cardiovascular disease, and neurodegenerative diseases. Phyto-nanoparticles have been shown to be effective in targeting specific cells or tissues, resulting in more efficient treatments with fewer side effects. Moreover, the use of plant-based materials in nanomedicine offers a sustainable and eco-friendly alternative to traditional pharmaceuticals. As a result, there is increasing interest in the development of phyto-nanoparticles for various medical applications.

This Article Collection aims to showcase the latest research in phyto-nanomedicine and highlight the potential of plant-based nanoparticles for medical applications. By bringing together researchers from different fields, this Article Collection offers a platform to exchange ideas, share findings, and discuss the future directions and challenges of this exciting field. Through this initiative, we hope to inspire further innovation and exploration of phyto-nanomedicine, ultimately leading to improved patient outcomes and a more sustainable approach to medicine.

Potential subtopics related to recurrent miscarriage include (but are not limited to):
• Development and characterization of plant-based nanoparticles for medical applications
• Purification, characterization and bioengineering of plant extracellular vesicles and/or plant-derived nanovesicles
• Applications of phyto-nanoparticles in disease treatment, including cancer, cardiovascular disease, and neurodegenerative diseases
• Biocompatibility and safety of phyto-nanoparticles
• Delivery and targeting of phyto-nanoparticles in vivo
• Synergistic effects of combining phyto-nanoparticles with other therapies
• Future directions and challenges in the field of phyto-nanomedicine

Guidelines for contributors:
Contributors are invited to submit original research articles, reviews, or perspective papers related to the subtopics mentioned above. The manuscripts should present novel findings, critical analysis, and prospects in the field of phyto-nanomedicine. All submissions will be subjected to rigorous peer-review processes to ensure high-quality publications.
Please contact Haoyang Yi at [email protected]is.com with any queries regarding this Article Collection.

Guest advisor:
Dr. Alfredo Ambrosone, University of Salerno
[email protected]
Prof. Ambrosone completed his PhD in Biotechnological Sciences at the University of Naples "Federico II" in 2008. His academic journey provided him with a multidisciplinary background in biotechnology and nanotechnology, with a specific focus on their application to both plant species and invertebrate animals. As part of his achievements, he was honored with a Marie Curie Individual Fellowship through the Excellent Science - Horizon 2020 program.
Currently, Prof. Ambrosone holds the position of Associate Professor of Plant Genetics and Genetic Diversity at the Department of Pharmacy (University of Salerno, Italy). His primary research interests lie in exploring the genetic and molecular factors that govern plant growth and the biosynthesis of secondary metabolites in response to abiotic stresses. In recent years, he has directed his investigations towards the examination of the role played by plant extracellular vesicles in plant protection and human health. Additionally, his current studies are also focused on the implementation of new nano-enabled technology for crop improvement and protection. His publications span various esteemed journals, including ACS Nano, NanoToday, Biomaterials, Environmental Science and Technology, and Plant Physiology.

The deadline for submissions is 31st December 2023.

Please submit your manuscript on our website, quoting the promo code XZIER to indicate that your submission is for consideration in this Article Collection.

View all papers in this article collection

Call For Papers

Editor-in-Chief: Dr Israel Rubinstein

To see where the International Journal of Nanomedicine is indexed online view the Journal Metrics.

What is the advantage to you of publishing in the International Journal of Nanomedicine?

It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
Although the International Journal of Nanomedicine receives a large number of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. The International Journal of Nanomedicine has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed Central
The International Journal of Nanomedicine is indexed on PubMed Central and MedLine (title abbreviation: Int J Nanomedicine). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely
Dr Israel Rubinstein
Editor-in-Chief
International Journal of Nanomedicine

Email: Editor-in-Chief